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Abstract 
Review on t(1;5)(q12-q25;q13-q35), with data on 
clinics. 
Clinics and pathology 
Disease 
Myeloid malignancies, acute lymphoblastic 
leukemia (ALL) multiple myeloma (MM), B- and T- 
cell lymphoma and sporadic cases of other 
malignancies. 
Phenotype/cell stem origin 
Myeloid malignancies in 10 patients: 1 chronic 
myeloid leukemia (CML) (Dastugue et al., 1986), 3 
myelodysplastic syndromes (MDS) (Furuya et al., 
1992;  Johansson et al., 1997; Quentin et al., 2011) 
and 6 acute myeloid leukemia (AML) cases (Gyger 
et al., 1989; Shikano et al., 1993; Wong et al., 1993; 
Borkhardt et al., 2000; Van Limbergen et al., 2002; 
Jekarl et al., 2010).   
Acute lymphoblastic leukemia in 8 cases 
(Saikevych et al., 1991; Martin et al., 1996; Rieder 
et al., 1996; van den Berghe  et al., 2000; Chang et 
al., 2006; Wehrli et al., 2009; Paulsson et al ., 2015; 
Safavi et al., 2015).  
Multiple myeloma in 11 cases (Smadja et al., 2001; 
Smadja et al., 2003. Nilsson et al., 2002; Mohamed 
et al., 2007;  Lim et al., 2013;  Sawyer et al., 2014). 
B-cell neoplasms: follicular lymphoma in 3 (Le 
Baccon et al.,  2001; Horsman et al., 2003; Johnson 
et al., 2008), diffuse large B-cell lymphoma in 4 
(Jonveaux et al., 1990; Jerkeman et al., 1999; 
 Yoshioka et al., 2005; Ruminy et al., 2006)  and 
mature B-cell neoplasm (Tanaka et al., 2001) in 1 
patient. 
T-cell neoplasms: reported in one case each of 
peripheral T-cell lymphoma (Schlegelberger et al., 
1994), hepatosplenic T-cell lymphoma (Ott et 
al.,1998),  and mycosis fungoides/Sezary syndrome 
(Perez-Vila  et al., 2000).  
Epidemiology 
At least 40 reported cases; balanced sex ratio 
(22M/18F aged 0 to 76 years).  
Male prevalence in myeloid (7M/3F, aged 0 to 76 
years) and ALL cases (6M/2F, aged 2 to 70 years). 
There were 5 males and 6 female MM patients (aged 
39 to 73 years) and 4M/7F cases in other 
malignancies group (aged 28 to 90 years) (Table 1). 
Prognosis 
The prognosis is likely unfavorable in association 




Unbalanced translocation, characterized by the 
presence of 2 copies of normal chromosome 1, only 
1 copy of normal chromosome 5 and a derivative 
chromosome 5, containing 1q.   
Presents as 2 normal chromosomes 1 and 5 and a 
+der(5)t(1;5) chromosome in 14 out of 40 cases. The 
breakpoints in 1q varied from 1q12 to q25 and were 
located on 5q13-q35. 




















2 M/57 AML-M1 
43,XY,-1,del(5)(q13q33),der(5)t(1;5)(q23;q33),-7,add(8)(p23),del(11)(p15),add(12)(p11),-14,-
16,-17,+2mar 
3 M/76 MDS 46,XY,der(5)t(1;5)(q21;q35)/46,XY,+der(1)t(1;7)(p11;p11),-7 
4 F/0     







7 M/6 AML 
46,XY,der(1)add(1)(p36)add(1)(q32),der(5)t(1;5)(q25;q22),add(6)(q15),del(7)(p14p15),del(17)(
p12) 
8 M/76 AML-M2 45,XY,der(1)t(1;5)(q21;q33),der(3)t(3;6)(q21;q22),der(?3)r(3;6),der(5)t(1;5)(q21;q13),-18 












11 F/70 BAL 46,XX,t(9;22)(q34;q11)/46,idem,der(5)t(1;5)(q22;q35)/46,idem,der(6)t(1;6)(q22;q27) 
12 M ALL 59,XXY,+Y,-1,-2,-3,der(5)t(1;5)(q21;q21),-7,-9,-11,-12,-13,-16,-19,-20,+21,-22 
13 M/57 B-ALL 48,XY,der(5)t(1;5)(q12-21;q35),+8,-9,t(9;22)(q34;q11),+14,+der(22)t(9;22) 
14 M ALL 58,XXY,-1,-2,-3,der(5)t(1;5)(q23;q31),-7,-8,-9,+10,-11,-12,-13,-15,-16,+18,-19,-20 
15 M/4 ALL 51-55,XY,+der(5)t(1;5)(q12;q31),+6,+10,+18,+18,+21,+21 
16 M/9 ALL 47,X,-Y,+der(5)t(1;5)(q21;q31),-8,del(9)(p13),+13,+mar 
17 M/2 ALL 62,XY,+X,+Y,+der(5)t(1;5)(q12;q21),+6,+8,+9,+10,+11,+12,+14,+14,+17,+18,+21,+21,+22 
18 F/22 ALL 46,XX,t(1;5)(q21;q32)/42-48,idem,+8/48,idem,+der(5)t(1;5),+21 
  Multiple 
myeloma 
 
19 M MM 
50,X,-Y,del(1)(p22p31),+3,+der(5)t(1;5)(q12;q35),+7,+9,del(11)(p11p12),add(12)(p13),-13,-
14,+15,+19,-22,+2mar/49,idem,-5 




21 F/51 MM 
45,XX,del(1)(p22p32),der(5)t(1;5)(q25;q35),-
10,t(11;14)(q13;q32),ins(13;12)(p11;q22q24),del(14)(q22) 
22 F/74 MM M 
44,X,-X,-1,inv(2)(p13q37),der(5)t(1;5)(q21;q35),der(6)t(1;6)(q21;q21),+del(11)(q21),-13,-
14,der(17)(1;17)(p31;p13),+18,-20 




24 F/43 MM M 
46,XX,add(1)(p22),del(3)(p24),-5,der(5)t(1;5)(q13;q31),-8,-14,add(17)(p13),add(19)(p13),+1-
4mar 
25 F MM 
42,X,-X,del(1)(p13p32),der(2)t(1;2)(q21;q25),del(4)(q31),t(8;13)(q24;q11),del(12)(p11),-13,-
21/42,idem,der(5)t(1;5)(q21;q35),add(15)(p13),add(19)(q13) 
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26 F MM 
44,XX,+del(3)(q21q25),der(5)t(1;5)(q21;q35),der(8;14)(q10;q10),+der(8;14)(q10;q10),der(12;1
5)(q10;q10),-13,del(14)(q22q32),-22 
















  Other 
malignancies 
 
30 F/56 DLBCL LN 
52,XX,add(1)(q32),add(3)(q29),+der(5)t(1;5)(q23;q13),del(7)(p13),del(11)(q21),t(11;14)(q22;q
32),+add(18)(q23),+4mar 







32 M/28 HTCL LN 46,XY,del(1)(q25),der(5)t(1;5)(q25;q31),der(9)t(9;13)(p23-24;?q14),del(13)(q12) 











35 F/72 MBCN 
49,XX,-1,der(2)t(2;11)(q21;q21-22),+5,+der(5)t(1;5)(q21;q31),del(6)(q13q15),-
8,add(14)(q32),+18,+der(?)t(?;12)(?;q21)x2 
36 M/41 FL    
37 F/43 FL LN 47,XX,t(1;16)(p34;q24),ins(2;?)(p13;?),+der(5)t(1;5)(q24;q33),ins(7;?)(q22;?),ins(12;?)(q15;?) 
38 M DLBCL LN 
46,XY,der(1)t(1;13)(q32;q14),t(3;14)(q27;q32),der(5)t(1;5)(q25;q13),der(6)(1;6)(q25;q21),del(7
)(q22q32),add(8)(p21),del(8)(q22),inv(9)(p13q13),der(13)t(8;13)(q22;q12) 
39 M DLBCL LN 
54,XY,+X,+2,t(3;14)(q27;q32),+der(5)t(1;5)(q21;q13)x2,+del(6)(q12q27),+7,+11,+12,+add(17)
(q21) 
40 F FL LN 47,XX,t(1;16)(p34;q24),ins(2;?)(p13;?),+der(5)t(1;5)(q24;q33),ins(7;?)(q22;?),ins(12;?)q15;?) 
Table 1.  Reported cases with unbalanced chromosome translocations der(5)t(1;5) involving 1q12-q25 and 5q13-q35. 
1. Dastugue et al., 1986; 2. Gyger et al., 1989; 3. Furuya et al., 1992; 4. Shikano et al.,  1993; 5. Wong et al., 1993; 6. Johansson  
et al., 1997; 7. Borkhardt et al., 2000; 8. Van Limbergen et al., 2002; 9. Jekarl et al., 2010; 10. Quentin et al., 2011; 11. 
Saikevych et  al., 1991; 12. Martin et al., 1996; 13. Rieder et al., 1996; 14. van den Berghe et al., 2000; 15. Chang et al., 2006; 
16. Wehrli et al., 2009;  17. Paulsson et al ., 2015; 18. Safavi et al., 2015; 19.  Smadja et al., 2001; 20. Smadja et al., 2003. 21. 
Nilsson et al., 2002;  22-24. Mohamed et al., 2007; 25-26. Lim et al., 2013; 27-29. Sawyer et al., 2014; 30. Jonveaux et al., 1990; 
31. Schlegelberger et al., 1994; 32. Ott et al.,1998; 33. Jerkeman et al.,  1999; 34. Perez-Vila et al., 2000; 35. Tanaka et al., 
2001; 36. Le  Baccon et al., 2001; 37. Horsman et al., 2003; 38.Yoshioka et al., 2005; 39. Ruminy et al., 2006; 40. Johnson et al., 
2008.  
M., male; F., female; CML., chronic myeloid  leukemia; AML-M1., acute myeloblastic leukemia without maturation; MDS.,  
myelodysplastic syndrome; AML-M0., acute  myeloblastic leukemia with minimal differentiation; AML., acute myeloid  leukemia; 
AML-M2., acute  myeloblastic leukemia with maturation; BAL., bilineage or biphenotypic  leukemia; ALL., acute lymphoblastic 
leukemia; MM., multiple myeloma; DLBCL., diffuse large B-cell lymphoma; LN., lymph node; PTCL., peripheral  T-cell 
lymphoma ; HTCL., hepatosplenic T-cell lymphoma; MF/SS., mycosis fungoides/Sezary syndrome;  MBCN., mature B-cell 
neoplasm; FL., follicular lymphoma. 
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Additional anomalies 
Appears as a sole chromosomal abnormality in 2 
MDS patients: in a 5-years old boy with Fanconi 
anemia (Quentin et al., 2011) and in a 64-years old 
male who received therapy for Hodgkin disease 
(Johansson et al., 1997).  Found in association with 
t(9;22) in a CML (Dastugue et al., 1986) and in 2 
ALL cases (Saikevych et al., 1991;  Rieder et al., 
1996).  Presents as a sole structural abnormality in 
association with numerical anomalies in 5 out of 8 
ALL cases (Martin et al., 1996; van den Berghe  et 
al., 2000; Chang et al., 2006;  Paulsson et al ., 2015; 
Safavi et al., 2015) and complex karyotypes in the 
remaining patients. Associated with additional 
unbalanced chromosome 1q abnormalities in 3 
myeloid (Furuya et al., 1992; Shikano et al., 1993; 
Van Limbergen et al., 2002), 1 ALL (Saikevych et 
al.,  1991),  6 MM (Smadja et al., 2003; Mohamed et 
al., 2007; Lim et al., 2013; Sawyer et al., 2014) and 
2 lymphoma patients (Le Baccon et al.,  2001;  
Yoshioka et al., 2005). 
Genes involved and 
proteins 
Note 
The balanced t(1;5)(q21;q33) results in TPM3 / 
PDGFRB and the t(1;5)(q23;q33) in PDE4DIP 
/PDGFRB fusion that are sensitive to inhibition with 
imatinib (Wilkinson et al., 2003; Rosati et al., 2006; 
Cheah et al., 2014) in chronic myeloproliferative 
disorders 




Unbalanced translocations between 1q and 5q are 
chromosomal abnormalities detectable in a broad 
spectrum of haematological malignancies including 
both lymphoid and myeloid neoplasms. Although 
cytogenetically heterogeneous, the main 
consequence of this rearrangement is a genomic 
imbalance resulting from gain of genes on 1q 
associated with partial 5q monosomy. Trisomies of 
genes located on the long arm of chromosome 1 are 
likely be implicated in neoplastic processes by a 
gene dosage effect resulting in overexpression of  
several genes. Alternatively, effects of the 
concomitant partial aneuploidy of genes on the 
partner chromosome 5 may play a role.  Deletion of 
genes located on the long arm of chromosome 5 is a 
well-known chromosomal abnormality in 
myeloproliferative malignancies, therefore loss of 
the genes from 5q may be involved in neoplastic 
transformation and/or disease progression in these 
disorders. Although der(5)t(1;5)(q12-q25;q13-q35) 
was found as the sole abnormality in 2 patients, it 
usually presents with primary abnormalities such as 
t(9;22), 5q-, trisomy 8, monosomy 7 in myeloid 
malignancies, hyperploidy in ALL, complex 
karyotypes in MM and lymphomas, therefore it  is 
apparently a secondary event preceding or 
accompanying disease evolution. The observation of 
this anomaly in highly complex karyotypes may be 
predictive of unfavorable prognosis in hematologic 
malignancies. 
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